Investor Relations

About

Our Company comprises an innovative business model centred around the development and commercialisation of medical diagnostic and monitoring technology. Our two main technologies are the BodyTel system, which is a system that facilitates the management, diagnosis and evaluation of chronic diseases, and the My-Lifespot system, which is a system that facilitates the diagnosis and evaluation of skin diseases. The BodyTel System is already operational in Germany while the My-Lifespot system is in the stages of development.

Listing

Australian Securities Exchange
ASX code: LSH

Please refer to the ASX website for the Company’s current share price and history.

Head Office

C/- Pointon Partners Lawyers
Level 14, 565 Bourke St
Melbourne VIC 3000
Australia

Share Registry

Computershare Investor Services Pty Limited
452 Johnston Street
Abbotsford  VIC  3067

Board of Directors

Mr Tilo Brandis (Non-Executive Chairman)
Mr Heiner Emden (Executive Director)
Mr Francesco Cannavo (Non-Executive Director)
Mr Mark Talbot (Non-Executive Director)

Incoming Director of the Company

Dr Philip Bekhor (Non-Executive Director)

Investor Relations Contact

Mr Frank Cannavo
Investor Relations

Level 14/565 Bourke Street
Melbourne VIC 3000
Phone:
Mobile:

Mr Niv Dagan
Peak Asset Management

Level 39/55 Collins Street
Melbourne VIC 3000
Phone: 1300 304 460
Mobile: 0402 912 198